- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Gilead Sciences Inc. (NASDAQ:GILD): Current Price: $79.02
According to RBC Capital expectations, investors over the next 12-20 months may start giving Gilead credit for the development of a new HIV treatment that will be able to replace its current Viread treatment which is going generic in 2019. The firm believes that the stock may move towards or over $100 due to this factor, and it keeps its Outperform rating on the stock.
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.